Data / Form D filings / Hemanext Inc.
Hemanext Inc.: Form D filings
Hemanext Inc., a health care company in Lexington, MA, filed 13 Form D notices with the SEC between 2013 and 2025. The latest, on August 5, 2025, reports $20 million sold of a $24 million offering to 29 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 99 HAYDEN AVENUE, BUILDING B, SUITE 620, Lexington, MA, 02421
- Phone
- (781) 301-7463
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1305849
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | New notice | $24,000,000 | $19,978,442 | $4,021,558 | 29 | Jul 18, 2025 | sec.gov |
| Jul 31, 2025 | New notice | $21,714,277 | $21,714,277 | 51 | Nov 7, 2024 | sec.gov | |
| Jan 8, 2024 | New notice | $10,000,000 | $5,005,000 | $4,995,000 | 10 | Dec 18, 2023 | sec.gov |
| Nov 8, 2023 | New notice | $11,285,000 | $11,285,000 | 20 | Jun 21, 2023 | sec.gov | |
| Feb 7, 2023 | New notice | $15,000,000 | $13,248,996 | $1,751,004 | 38 | Jul 19, 2022 | sec.gov |
| Oct 15, 2021 | Amendment | $59,475,000 | $39,636,597 | $19,838,403 | 39 | Aug 8, 2019 | sec.gov |
| Oct 23, 2020 | Amendment | $44,470,000 | $21,220,000 | $23,250,000 | 10 | Aug 8, 2019 | sec.gov |
| Oct 25, 2019 | New notice | $14,500,000 | $4,425,000 | $10,075,000 | 7 | Aug 8, 2019 | sec.gov |
| Oct 26, 2018 | Amendment | $16,000,000 | $8,750,000 | $7,250,000 | 6 | Feb 2, 2018 | sec.gov |
| Feb 6, 2018 | New notice | $2,500,000 | $2,000,000 | $500,000 | 2 | Feb 2, 2018 | sec.gov |
| Dec 19, 2017 | New notice | $5,000,000 | $2,700,000 | $2,300,000 | 6 | Oct 24, 2017 | sec.gov |
| Dec 20, 2016 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Dec 16, 2013 | New notice | $17,600,000 | $12,281,936 | $5,318,064 | 3 | Jul 22, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert J. Haime | Executive Officer | |
| Eric J. Newman | Executive Officer | |
| Peter A. Testa | Director | |
| Daan M. Kok | Executive Officer | |
| Paul M. Ness | Director | |
| Geoffrey M. Crouse | Director | |
| Andrew Dunham | Executive Officer, Director | |
| Laura J. Daniels | Executive Officer | |
| Eduardo Patrick Avayu | Director | |
| Philip M. Pead | Director | |
| Stephen A. Eckert | Director | |
| Joseph M. Grogan | Director | |
| Laurel J. Omert | Executive Officer | |
| Ismail M. Kola | Director | |
| William Patrick O'Neill | Director | |
| Jill J. Buckley | Executive Officer |
Other health care companies in Massachusetts that filed recently
- XRHealth, Inc. $3.9 million · Oct 23, 2026
- Fresenius Medical Care Fulshear, LLC $4.4 million · Oct 21, 2026
- Nocturnal Inc. $1.9 million · Oct 20, 2026
- Mikri Inc. $1.4 million · Oct 19, 2026
- Soterya, Inc. $850,000 · Oct 13, 2026
- ArthroMeda, Inc. $8.7 million · Oct 13, 2026
Every Form D from the week of Aug 4, 2025 · All recent filings in Massachusetts · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Hemanext Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.